Published in Leuk Res on May 01, 1995
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Health insurance and access to primary care for children. N Engl J Med (1998) 7.09
Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J (1972) 4.60
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58
Ferritin in serum. Clinical and biochemical implications. N Engl J Med (1975) 4.51
An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol (1972) 4.42
The unmet health needs of America's children. Pediatrics (2000) 3.45
A simple measure of insulin resistance. Lancet (1995) 3.44
Children's access to primary care: differences by race, income, and insurance status. Pediatrics (1996) 3.24
Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia (2010) 2.30
Social support and the outcome of major depression. Br J Psychiatry (1989) 2.30
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia (2010) 2.23
The role of Medicaid in ensuring children's access to care. JAMA (1998) 2.13
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Low molecular weight intracellular iron transport compounds. Blood (1977) 2.02
Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet (1972) 2.01
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia (2013) 1.97
A system for data processing in haematology. J Clin Pathol (1974) 1.95
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet (2001) 1.94
Mammalian mitochondria possess homologous DNA recombination activity. J Biol Chem (1996) 1.94
Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics (1993) 1.94
Guidelines for the use of recombinant human erythropoietin. Haematologica (1995) 1.94
Mortality in the mentally handicapped: a 50 year survey at the Stoke Park group of hospitals (1930-1980). J Ment Defic Res (1983) 1.84
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Identification of two human ferritin H genes on the short arm of chromosome 6. Genomics (1990) 1.79
Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res (2000) 1.78
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D. Eur J Clin Nutr (2001) 1.77
Quality assurance in general practice: the state of the art in Europe. Fam Pract (1994) 1.75
The characteristics of ferritin from human tissues, serum and blood cells. Clin Sci Mol Med (1975) 1.75
Shortfall in mental health service utilisation. Br J Psychiatry (2001) 1.75
Outdoor air pollution, climatic changes and allergic bronchial asthma. Eur Respir J (2002) 1.64
T-DNA integration patterns in co-transformed plant cells suggest that T-DNA repeats originate from co-integration of separate T-DNAs. Plant J (1997) 1.64
A novel transforming gene in a human malignant melanoma cell line. Nature (1984) 1.63
Iron metabolism, sickle cell disease, and response to cyanate. Blood (1975) 1.60
Experimental observation of the improvement in MTF from backthinning a CMOS direct electron detector. Ultramicroscopy (2009) 1.60
FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci U S A (1990) 1.58
Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc (2000) 1.58
Serum ferritin in acute leukaemia at presentation and during remission. Br Med J (1975) 1.57
Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci (1997) 1.57
The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol (1971) 1.53
Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet (1994) 1.52
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia (2010) 1.51
Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev (2011) 1.50
The epidemiology of depression in an elderly community population. Gerontologist (1987) 1.49
Ferritin synthesis in normal and leukaemic leukocytes. Nature (1974) 1.48
Stomatal vs. genome size in angiosperms: the somatic tail wagging the genomic dog? Ann Bot (2010) 1.47
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia (2006) 1.45
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
The effect on children of curtailing Medicaid spending. JAMA (1995) 1.44
Replacing 99Tcm-DMSA for renal imaging? Nucl Med Commun (1992) 1.43
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia (1998) 1.42
The DNA sequences of T-DNA junctions suggest that complex T-DNA loci are formed by a recombination process resembling T-DNA integration. Plant J (1999) 1.41
A rapid method for the detection of ferritin in serum. J Clin Pathol (1971) 1.41
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia. Leukemia (1995) 1.39
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). Eur Psychiatry (2009) 1.38
Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology (1997) 1.38
Trilostane as cause of Addisonian crisis. Lancet (1981) 1.38
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med (1994) 1.38
Properties of human tissue isoferritins. Biochem J (1978) 1.37
Evolutionary divergence of genes for ornithine and aspartate carbamoyl-transferases--complete sequence and mode of regulation of the Escherichia coli argF gene; comparison of argF with argI and pyrB. Nucleic Acids Res (1984) 1.37
Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer (1973) 1.37
Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. Psychol Med (1988) 1.37
Children with chronic illness and Medicaid managed care. Pediatrics (1994) 1.36
Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol (1985) 1.36
Haemoglobin estimation: a comparison of different techniques. Br Med J (1966) 1.35
Ferritin in normal erythrocytes, lymphocytes, polymorphs, and monocytes. Br J Haematol (1974) 1.32
Functional impairment and utilization of services associated with posttraumatic stress in the community. J Trauma Stress (1999) 1.31
Activation of N-ras in a human melanoma cell line. Mol Cell Biol (1985) 1.30
A model of the impact of reimbursement schemes on health plan choice. J Health Econ (1998) 1.30
Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol (1999) 1.29
Molecular imaging of gene therapy for cancer. Gene Ther (2004) 1.28
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum Gene Ther (1997) 1.26
Human preleukaemia: do we have a model? Br J Cancer (1987) 1.25
Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol (1979) 1.25
Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J Lab Clin Med (1991) 1.25
Cognitive rehabilitation as a component of early intervention in Alzheimer's disease: a single case study. Aging Ment Health (2003) 1.25
Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery (2001) 1.25
Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe. Br J Haematol (1975) 1.25
Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine. Biochim Biophys Acta (1978) 1.25
Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration. Gut (1975) 1.24
The purification and properties of ferritin from human serum. Biochem J (1976) 1.24
Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. Br J Haematol (1980) 1.23
Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther (1995) 1.23
Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay. J Virol Methods (1999) 1.22
Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol (1999) 1.21
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther (1995) 1.20
Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br J Haematol (1998) 1.20
Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis. Br J Haematol (1974) 1.20
Is leaf dry matter content a better predictor of soil fertility than specific leaf area? Ann Bot (2011) 1.20